{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:05:29Z","timestamp":1790960729424,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013275","name":"Instituto Serrapilheira","doi-asserted-by":"publisher","award":["401209\/2020-2"],"award-info":[{"award-number":["401209\/2020-2"]}],"id":[{"id":"10.13039\/501100013275","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"FAPERJ","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Engineering Journal"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.bej.2022.108537","type":"journal-article","created":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T04:03:02Z","timestamp":1657944182000},"page":"108537","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["From a recombinant key antigen to an accurate, affordable serological test: Lessons learnt from COVID-19 for future pandemics"],"prefix":"10.1016","volume":"186","author":[{"given":"Renata G.F.","family":"Alvim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tulio M.","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle A.S.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico F.","family":"Marsili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente B.T.","family":"Bozza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiza M.","family":"Higa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio L.","family":"Monteiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P.B.","family":"Abreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabela C.","family":"Leit\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato S.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael M.","family":"Galliez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terezinha M.P.P.","family":"Castineiras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo H.","family":"Travassos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Nobrega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amilcar","family":"Tanuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Orlando C.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 M.","family":"Vale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leda R.","family":"Castilho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bej.2022.108537_bib1","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1016\/j.vaccine.2017.05.032","article-title":"ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice","volume":"35","author":"Alharbi","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.bej.2022.108537_bib2","doi-asserted-by":"crossref","first-page":"6970","DOI":"10.1016\/j.vaccine.2019.05.064","article-title":"Zika virus-like particles (VLPs): Stable cell lines and continuous perfusion processes as a new potential vaccine manufacturing platform","volume":"37","author":"Alvim","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.bej.2022.108537_bib3","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1002\/bit.27864","article-title":"Process intensification for the production of yellow fever virus-like particles as potential recombinant vaccine antigen","volume":"118","author":"Alvim","year":"2021","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.bej.2022.108537_bib4","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/s41591-020-0913-5","article-title":"A serological assay to detect SARS-CoV-2 seroconversion in humans","volume":"26","author":"Amanat","year":"2020","journal-title":"Nat. Med"},{"key":"10.1016\/j.bej.2022.108537_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.808932","article-title":"Spike-dependent opsonization indicates both dose-dependent inhibition of phagocytosis and that non-neutralizing antibodies can confer protection to SARS-CoV-2","volume":"12","author":"Bahnan","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.bej.2022.108537_bib6","doi-asserted-by":"crossref","first-page":"78","DOI":"10.11606\/s1518-8787.2021055004075","article-title":"Population-level seropositivity trend for SARS-Cov-2 in Rio Grande do Sul, Brazil","volume":"55","author":"Barros","year":"2021","journal-title":"Rev. Saude Publica"},{"key":"10.1016\/j.bej.2022.108537_bib7","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41586-019-1717-y","article-title":"A new twenty-first century science for effective epidemic response","volume":"575","author":"Bedford","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.bej.2022.108537_bib8","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(22)00055-1","article-title":"Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial","volume":"399","author":"Bravo","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.bej.2022.108537_bib9","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1172\/JCI135003","article-title":"Climate change brings the specter of new infectious diseases","volume":"130","author":"Casadevall","year":"2020","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.bej.2022.108537_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0261003","article-title":"COVID-19 Immunity Task Force (CITF) working group. Dried blood spot specimens for SARS-CoV-2 antibody testing: A multi-site, multi-assay comparison","volume":"16","author":"Cholette","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.bej.2022.108537_bib11","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41586-020-2622-0","article-title":"SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness","volume":"586","author":"Corbett","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bej.2022.108537_bib12","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1016\/j.vaccine.2021.05.063","article-title":"Evidence for antibody as a protective correlate for COVID-19 vaccines","volume":"39","author":"Earle","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.bej.2022.108537_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.pep.2020.105686","article-title":"Optimizing high-yield production of SARS-CoV-2 soluble spike trimers for serology assays","volume":"174","author":"Esposito","year":"2020","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.bej.2022.108537_bib14","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S1473-3099(20)30160-2","article-title":"Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial","volume":"20","author":"Folegatti","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.bej.2022.108537_bib15","first-page":"22","article-title":"Identification of conserved epitopes in SARS-CoV-2 spike and nucleocapsid protein","author":"Forcelloni","year":"2021","journal-title":"Curr. Genom."},{"key":"10.1016\/j.bej.2022.108537_bib16","article-title":"Validation of a SARS-CoV-2 spike protein ELISA for use in contact investigations and serosurveillance","author":"Freeman","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.bej.2022.108537_bib17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1126\/science.abm3425","volume":"375","author":"Gilbert","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.bej.2022.108537_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198528","article-title":"Absorbance summation: A novel approach for analyzing high-throughput ELISA data in the absence of a standard","volume":"13","author":"Hartman","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.bej.2022.108537_bib19","unstructured":"Haseltine W.A., Tests for COVID-19 are expensive, but they don\u2019t have to be. Forbes 2020, April 8. \u3008https:\/\/www.forbes.com\/sites\/williamhaseltine\/2020\/04\/08\/pricing-and-profiteering-from-covid-19-tests\/?sh=3f6b6d5d1ccb\u3009, accessed on February 18, 2022."},{"key":"10.1016\/j.bej.2022.108537_bib20","unstructured":"Johns Hopkins University. Coronavirus Resource Center, 2022; \u3008https:\/\/coronavirus.jhu.edu\/map.html\u3009, accessed on February 16, 2022."},{"key":"10.1016\/j.bej.2022.108537_bib21","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection","volume":"27","author":"Khoury","year":"2021","journal-title":"Nat. Med"},{"key":"10.1016\/j.bej.2022.108537_bib22","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1126\/science.abc1227","article-title":"Serology assays to manage COVID-19","volume":"368","author":"Krammer","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.bej.2022.108537_bib23","doi-asserted-by":"crossref","first-page":"256","DOI":"10.4269\/ajtmh.17-0889","article-title":"Dried Blood Spots for Global Health Diagnostics and Surveillance: Opportunities and Challenges","volume":"99","author":"Lim","year":"2018","journal-title":"Am. J. Trop. Med Hyg."},{"key":"10.1016\/j.bej.2022.108537_bib24","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1365-2753.2005.00598.x","article-title":"Measuring diagnostic and predictive accuracy in disease management: an introduction to receiver operating characteristic (ROC) analysis","volume":"12","author":"Linden","year":"2006","journal-title":"J. Eval. Clin. Pr."},{"key":"10.1016\/j.bej.2022.108537_bib25","doi-asserted-by":"crossref","first-page":"m2516","DOI":"10.1136\/bmj.m2516","article-title":"Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis","volume":"370","author":"Lisboa-Bastos","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.bej.2022.108537_bib26","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2105482118","article-title":"Intensity and frequency of extreme novel epidemics","volume":"118","author":"Marani","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bej.2022.108537_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2021.104739","article-title":"EDSAB-HOME Study Investigators. Use of dried blood spot samples for SARS-CoV-2 antibody detection using the Roche Elecsys \u00ae high throughput immunoassay","volume":"136","author":"Mulchandani","year":"2021","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.bej.2022.108537_bib28","doi-asserted-by":"crossref","first-page":"07TR01","DOI":"10.1088\/1361-6560\/aab4b1","article-title":"Receiver operating characteristic (ROC) curves: review of methods with applications in diagnostic medicine","volume":"63","author":"Obuchowski","year":"2018","journal-title":"Phys. Med Biol."},{"key":"10.1016\/j.bej.2022.108537_bib29","unstructured":"Our World in Data, 2022. \u3008https:\/\/ourworldindata.org\/Covid-vaccinations#what-share-of-the-population-has-received-at-least-one-dose-of-the-Covid-19-vaccine\u3009 (accessed on 14 February 2022)."},{"key":"10.1016\/j.bej.2022.108537_bib30","series-title":"Plant Design and Economics for Chemical Engineers","author":"Peters","year":"2003"},{"key":"10.1016\/j.bej.2022.108537_bib31","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(20)31483-5","article-title":"ENE-COVID Study Group. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study","volume":"396","author":"Poll\u00e1n","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.bej.2022.108537_bib32","doi-asserted-by":"crossref","first-page":"5877","DOI":"10.1038\/s41467-021-26117-x","article-title":"SARS-CoV-2 binding and neutralizing antibody levels after Ad26.COV2.S vaccination predict durable protection in rhesus macaques","volume":"12","author":"Roozendaal","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bej.2022.108537_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.bjid.2021.101601","article-title":"EPICOVID-19 Group, Barros AJ, Vidaletti LP, Hartwig FP, Barros FC, Hallal PC, Horta BL. Time-dependent decay of detectable antibodies against SARS-CoV-2: A comparison of ELISA with two batches of a lateral-flow test","volume":"25","author":"Silveira","year":"2021","journal-title":"Braz. J. Infect. Dis."},{"key":"10.1016\/j.bej.2022.108537_bib34","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jviromet.2011.01.014","article-title":"Importance of the cutoff ratio for detecting antibodies against hepatitis A virus in oral fluids by enzyme immunoassay","volume":"173","author":"Tourinho","year":"2011","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.bej.2022.108537_bib35","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"}],"container-title":["Biochemical Engineering Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1369703X22002066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1369703X22002066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T06:52:59Z","timestamp":1761288779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1369703X22002066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":35,"alternative-id":["S1369703X22002066"],"URL":"https:\/\/doi.org\/10.1016\/j.bej.2022.108537","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.07.13.20152884","asserted-by":"object"}]},"ISSN":["1369-703X"],"issn-type":[{"value":"1369-703X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From a recombinant key antigen to an accurate, affordable serological test: Lessons learnt from COVID-19 for future pandemics","name":"articletitle","label":"Article Title"},{"value":"Biochemical Engineering Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bej.2022.108537","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108537"}}